Clinical Trial Update: Nutritional Supplement for Treating Chemotherapy Induced Neuropathy [Phase 4]

View source ↗

Summary

Phase 4 trial of a nutritional supplement for chemotherapy-induced neuropathy in cancer patients has completed enrollment and status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Pain Neuropathy
• Chemotherapy-induced Peripheral Neuropathy
• Neuropathy

Drugs mentioned

• Nutritional Supplement

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Cancer, Neuropathy | Phase 4 | Status: COMPLETED